Yazan Abou-Ismail/ LinkedIn
Jun 6, 2026, 23:30
Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
Yazan Abou-Ismail, Associate Professor of Hematology at the University of Utah, shared on LinkedIn:
”I had the opportunity to share some insights in this Medscape article on a snail-derived (Camaena cicatricose) compound being investigated as a potential novel anticoagulant with possibly improved bleeding profile.
So interesting!
Always great to see the landscape of thrombosis treatment evolve, and the interest in uncoupling thrombosis from hemostasis grow.
I weighed in on potential opportunities and some limitations.
Thank you Beth Rush for putting this together and including me!”
Stay updated with Hemostasis Today.
-
Jul 26, 2026, 01:35Moustafa Abdou: Ehlers-Danlos Syndrome – Why Collagen Matters for Hemostasis
-
Jul 26, 2026, 01:25Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
-
Jul 26, 2026, 01:06Christine Bork: Why Misinformation Around a Single Vitamin Postpartum is Putting Babies at Risk
-
Jul 26, 2026, 00:44A Significant Step Forward For People With Bleeding Disorders In The Dominican Republic – WFH
-
Jul 25, 2026, 18:00The Evolving Landscape of Factor Replacement Therapy – EAHAD
-
Jul 25, 2026, 17:43Heghine Khachatryan: Advancing Care for Women and Girls With Hemophilia
-
Jul 25, 2026, 17:00Revathy R Menon: A Memorable Milestone at the 39th ISBT Congress
-
Jul 25, 2026, 16:19Nicola Potere: From Scientific Exchange to Global Collaboration at ISTH 2026
-
Jul 25, 2026, 12:11Salma Abosabie: Honored to Have an Oral Presentation on Thromboinflammation at the ISTH 2026